New Treatment Approaches for Leukemias Emerging From Early Clinical Trials
New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy
Genasense Added To Chemo Improves Responses in CLL
Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen
Of Smokers Screened With CT In Study, 7% Have Lung Cancer
Insulin For Diabetes Increases Risk Of Colorectal Cancer
NCI-Approved Clinical Trials
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says
